NCT01682369 ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses Status COMPLETED Phase PHASE2
NCT01677689 Study to Investigate the Efficacy and Safety of Apomivir® Status NOT_YET_RECRUITING Phase PHASE2
NCT01676402 Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years Status COMPLETED Phase PHASE1
NCT01673425 Evaluating Immune Response to Seasonal FluMist in Healthy Adults Status TERMINATED Phase NA
NCT01665807 A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine Status COMPLETED Phase PHASE4
NCT01664793 From Innovation to Solutions: Childhood Influenza Vaccination Planning Status COMPLETED Phase NA
NCT01662583 Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children Status COMPLETED Phase NA
NCT01659086 Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age Status COMPLETED Phase PHASE1
NCT01658800 Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Status COMPLETED Phase PHASE1
NCT01654809 Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups Status COMPLETED Phase PHASE4
NCT01654224 Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting Status COMPLETED Phase PHASE4
NCT01653015 Live Versus Inactivated Influenza Vaccine Study in Hutterite Children Status COMPLETED Phase PHASE4
NCT01651663 A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold Status UNKNOWN Phase PHASE4
NCT01649713 Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season Status COMPLETED Phase PHASE4
NCT01646138 Influenza A 2009 H1N1 Challenge Study in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01640327 Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01640314 Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01631110 Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains Status COMPLETED Phase PHASE3